ESAB Stock Analysis: ESAB | NYSE
Metal Fabrication | NYSE, USA | Market Cap: 5.471m USD | 12M Return: -29.3% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 84.0M
EPS Trend: 78.8%
Qual. Beats: 0
Rev. Trend: 67.0%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 4.2 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
ESAB Corporation (NYSE: ESAB) is a global manufacturer of consumable products and equipment for cutting, joining, automated welding, and gas control applications. The company was founded in 1904 and is headquartered in North Bethesda, Maryland. It distributes its products through both independent distributors and a direct sales force, operating across Europe, Asia Pacific, South America, and the Middle East. As a constituent of the Industrials sector under the Industrial Machinery & Supplies & Components sub-industry, ESAB serves customers in fabrication, construction, energy, and transportation end markets that rely on welding and cutting technologies.
- Europe industrial slowdown pressures welding equipment demand
- Pricing actions and productivity drive margin expansion
- Reshoring and energy transition boost US fabrication demand
| Net Income: 207.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -3.10 > 1.0 |
| NWC/Revenue: 49.49% < 20% (prev 22.50%; Δ 26.99% < -1%) |
| CFO/TA 0.05 > 3% & CFO 272.1m > Net Income 207.0m |
| Net Debt (1.24b) to EBITDA (492.0m): 2.52 < 3 |
| Current Ratio: 2.97 > 1.5 & < 3 |
| Outstanding Shares: last quarter (60.9m) vs 12m ago 0.70% < -2% |
| Gross Margin: 35.40% > 18% (prev 38.02%; Δ -2.62% > 0.5%) |
| Asset Turnover: 59.13% > 50% (prev 64.71%; Δ -5.58% > 0%) |
| Interest Coverage Ratio: 4.42 > 6 (EBIT TTM 389.6m / Interest Expense TTM 88.1m) |
| A: 0.26 (Total Current Assets 2.17b - Total Current Liabilities 730.0m) / Total Assets 5.62b |
| B: 0.15 (Retained Earnings 842.3m / Total Assets 5.62b) |
| C: 0.08 (EBIT TTM 389.6m / Avg Total Assets 4.92b) |
| D: 0.65 (Book Value of Equity 2.19b / Total Liabilities 3.39b) |
| Altman-Z'' = 3.38 = A |
| DSRI: 1.10 (Receivables 488.5m/414.8m, Revenue 2.91b/2.73b) |
| GMI: 1.07 (GM 38.02% / 35.40%) |
| AQI: 0.88 (AQ_t 0.53 / AQ_t-1 0.60) |
| SGI: 1.07 (Revenue 2.91b / 2.73b) |
| TATA: -0.01 (NI 207.0m - CFO 272.1m) / TA 5.62b) |
| Beneish M = -2.90 (Cap -4..+1) = A |
As of July 13, 2026, the stock is trading at USD 89.16 with a total of 417,423 shares traded. Over the past week, the price has changed by -3.90%, over one month by -2.51%, over three months by -12.81% and over the past year by -29.33%.
Current recommended Stop Loss: 83.30 (which is 6.6% or 1.2 ATR below the current price).
ESAB has received a consensus analysts rating of 3.91. Therefore, it is recommended to buy ESAB.
- StrongBuy: 5
- Buy: 2
- Hold: 3
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 136.3 | 52.9% |
P/E Trailing = 23.295
P/E Forward = 15.7729
P/S = 1.8802
P/B = 2.6315
P/EG = 1.2563
Revenue TTM = 2.91b USD
EBIT TTM = 389.6m USD
EBITDA TTM = 492.0m USD
Long Term Debt = 2.03b USD (from longTermDebt, last quarter)
Short Term Debt = 26.1m USD (from shortTermDebt, last quarter)
Debt = 2.24b USD (from shortLongTermDebtTotal, last quarter) + Leases 103.9m
Net Debt = 1.24b USD (calculated: Debt 2.24b - CCE 1.00b)
Enterprise Value = 6.71b USD (5.47b + Debt 2.24b - CCE 1.00b)
Interest Coverage Ratio = 4.42 (Ebit TTM 389.6m / Interest Expense TTM 88.1m)
EV/FCF = 30.73x (Enterprise Value 6.71b / FCF TTM 218.4m)
FCF Yield = 3.25% (FCF TTM 218.4m / Enterprise Value 6.71b)
FCF Margin = 7.50% (FCF TTM 218.4m / Revenue TTM 2.91b)
Net Margin = 7.11% (Net Income TTM 207.0m / Revenue TTM 2.91b)
Gross Margin = 35.40% ((Revenue TTM 2.91b - Cost of Revenue TTM 1.88b) / Revenue TTM)
Gross Margin QoQ = 36.90% (prev 30.47%)
Tobins Q-Ratio = 1.19 (Enterprise Value 6.71b / Total Assets 5.62b)
Interest Expense / Debt = 3.93% (Interest Expense 88.1m / Debt 2.24b)
Taxrate = 20.58% (61.8m / 300.1m)
NOPAT = 309.4m (EBIT 389.6m * (1 - 20.58%))
Current Ratio = 2.97 (Total Current Assets 2.17b / Total Current Liabilities 730.0m)
Debt / Equity = 1.02 (Debt 2.24b / totalStockholderEquity, last quarter 2.19b)
Debt / EBITDA = 2.52 (Net Debt 1.24b / EBITDA 492.0m)
Debt / FCF = 5.67 (Net Debt 1.24b / FCF TTM 218.4m)
Total Stockholder Equity = 2.14b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.21% (Net Income 207.0m / Total Assets 5.62b)
RoE = 9.70% (Net Income TTM 207.0m / Total Stockholder Equity 2.14b)
RoCE = 9.35% (EBIT 389.6m / Capital Employed (Equity 2.14b + L.T.Debt 2.03b))
RoIC = 6.48% (NOPAT 309.4m / Invested Capital 4.78b)
WACC = 8.17% (E(5.47b)/V(7.72b) * Re(10.24%) + D(2.24b)/V(7.72b) * Rd(3.93%) * (1-Tc(0.21)))
Discount Rate = 10.24% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 11.64 | Cagr: 0.47%
[DCF] Terminal Value 73.10% ; FCFF base≈248.9m ; Y1≈218.3m ; Y5≈176.4m
[DCF] Fair Price = 25.61 (EV 2.83b - Net Debt 1.24b = Equity 1.59b / Shares 62.1m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 78.77 | EPS CAGR: 5.63% | SUE: -0.19 | # QB: 0
Revenue Correlation: 67.04 | Revenue CAGR: 1.53% | SUE: 0.83 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.40 | Chg30d=-2.01% | Revisions=-50% | Analysts=5
EPS next Quarter (2026-09-30): EPS=1.48 | Chg30d=-2.19% | Revisions=+17% | Analysts=5
EPS current Year (2026-12-31): EPS=5.74 | Chg30d=-0.74% | Revisions=-50% | GrowthEPS=+8.9% | GrowthRev=+12.6%
EPS next Year (2027-12-31): EPS=6.69 | Chg30d=-5.41% | Revisions=+50% | GrowthEPS=+16.6% | GrowthRev=+8.2%
[Analyst] Revisions Ratio: -13% (up=5, down=7)